The effectiveness of Chinese-made vaccines is emerging as an enduring narrative in the U.S. media due in part to resurgent infection rates in countries that have relied heavily on Sinopharm and Sinovac jabs.

But a lot of this coverage lacks nuance and is simply associating the higher infection rate with the presence of Chinese vaccines without delving into detail about which segments of the population are becoming infected and why. For example, the majority of new infections in countries like the Seychelles are from people who are either unvaccinated or became infected prior to the two-week period it takes for the the vaccines to take full effect.